In an article entitled, "Adult Stem Cells are a Promising Market", investment analysts cite the many financial and scientific advantages of adult stem cells over embryonic stem cells.
The U.S. company NeoStem announces the signing of a new 10-year agreement with the Shanghai-based corporation Enhance BioMedical Holdings for the development of a network of adult stem cell treatment centers in China.
A new study sheds light on the ways by which damaged stem cells cause gray hair.
A New York woman reports that her ten-year-old autistic daughter has significantly improved after receiving adult stem cell therapy in Germany.
Three people in Australia have regained their sight after receiving a novel type of adult stem cell therapy.
Nearly 50,000 people have submitted their opinions to the National Institutes of Health regarding the new stem cell guidelines.
